225 related articles for article (PubMed ID: 12711157)
21. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
22. [Study on pulmonary delivery system of salmon calcitonin in rats].
Wang Z; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):329-32. PubMed ID: 12914259
[TBL] [Abstract][Full Text] [Related]
23. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.
Gradauer K; Barthelmes J; Vonach C; Almer G; Mangge H; Teubl B; Roblegg E; Dünnhaupt S; Fröhlich E; Bernkop-Schnürch A; Prassl R
J Control Release; 2013 Dec; 172(3):872-8. PubMed ID: 24140721
[TBL] [Abstract][Full Text] [Related]
24. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Schipper NG; Romeijn SG; Verhoef JC; Merkus FW
Pharm Res; 1993 May; 10(5):682-6. PubMed ID: 8321831
[TBL] [Abstract][Full Text] [Related]
25. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
[TBL] [Abstract][Full Text] [Related]
26. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies.
Yang T; Hussain A; Paulson J; Abbruscato TJ; Ahsan F
Pharm Res; 2004 Jul; 21(7):1127-36. PubMed ID: 15290851
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
[TBL] [Abstract][Full Text] [Related]
28. [Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Chen XM; Zhu JB; Sun WD; Zhang LJ
Yao Xue Xue Bao; 2006 Feb; 41(2):149-55. PubMed ID: 16671546
[TBL] [Abstract][Full Text] [Related]
29. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
Merkus FW; Verhoef JC; Romeijn SG; Schipper NG
Pharm Res; 1991 May; 8(5):588-92. PubMed ID: 1866372
[TBL] [Abstract][Full Text] [Related]
30. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
[TBL] [Abstract][Full Text] [Related]
31. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
32. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
33. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang Y; Jiang XG; Yao J
Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin.
Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI
Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932
[TBL] [Abstract][Full Text] [Related]
35. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.
Matsubara K; Abe K; Irie T; Uekama K
J Pharm Sci; 1995 Nov; 84(11):1295-300. PubMed ID: 8587046
[TBL] [Abstract][Full Text] [Related]
36. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
[TBL] [Abstract][Full Text] [Related]
37. Stability of PEGylated salmon calcitonin in nasal mucosa.
Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
39. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa.
Asai K; Morishita M; Katsuta H; Hosoda S; Shinomiya K; Noro M; Nagai T; Takayama K
Int J Pharm; 2002 Oct; 246(1-2):25-35. PubMed ID: 12270606
[TBL] [Abstract][Full Text] [Related]
40. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
